Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Azaya introduces new CDMO unit
August 2013
SHARING OPTIONS:

SAN ANTONIO—Oncology company Azaya Therapeutics Inc. has launched a new division, Parexo Labs, a contract development and manufacturing organization that will offer chemical testing and liposomal manufacturing services to outside organizations. The new unit will provide laboratory services that can accelerate drug development and regulatory progress for pharmaceutical and medical device developers. Parexo Labs will offer services for method development and validation for cytotoxics, raw material testing, stability storage and testing, chemical characterization and other analyses. Customized liposome manufacturing services will also be provided.
 
"Chemotherapy and nanotechnology continue to be at the forefront of cancer treatment options," said Don Kruppa, Azaya's vice president of operations. "Building on Azaya's drug development and manufacturing expertise, Parexo Labs can offer both commercial and academic customers innovative solutions in nanoparticle characterization and analysis, as well as the latest nanoparticle testing technology."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.